Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 4:55 pm Sale | 2022-12-31 | 13G | SHELTER ACQUISITION CORP I CL SHQA | FARALLON CAPITAL PARTNERS LP | 0 0.000% | -1,650,000 (Position Closed) | Filing History |
| 2023-02-09 4:55 pm Purchase | 2022-12-31 | 13G | SWIFTMERGE ACQUISITION CORP CL IVCP | FARALLON CAPITAL PARTNERS LP | 2,205,000 9.700% | 2,205,000 (New Position) | Filing History |
| 2023-02-09 4:54 pm Purchase | 2022-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | FARALLON CAPITAL PARTNERS LP | 5,055,102 9.990% | 5,055,102 (New Position) | Filing History |
| 2023-02-07 5:10 pm Sale | 2022-12-31 | 13G | BETTER THERAPEUTICS INC BTTX | FARALLON CAPITAL PARTNERS LP | 813,556 3.400% | -536,444 (-39.74%) | Filing History |
| 2023-02-07 5:09 pm Sale | 2022-12-31 | 13G | CLARIVATE PLC CLVT | FARALLON CAPITAL PARTNERS LP | 15,177,433 2.300% | -20,148,467 (-57.04%) | Filing History |
| 2023-02-07 5:09 pm Purchase | 2022-12-31 | 13G | AMYRIS INC AMRSQ | FARALLON CAPITAL PARTNERS LP | 1,000,000 0.300% | 1,000,000 (New Position) | Filing History |
| 2023-02-06 4:20 pm Sale | 2022-12-31 | 13G | SEP ACQUISITION CORP SEPA | FARALLON CAPITAL PARTNERS LP | 0 0.000% | -1,732,500 (Position Closed) | Filing History |
| 2023-02-06 09:06 am Purchase | 2022-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | FARALLON CAPITAL PARTNERS LP | 1,550,000 7.500% | 1,550,000 (New Position) | Filing History |
| 2023-02-03 5:16 pm Purchase | 2022-12-31 | 13G | SAVARA INC SVRA | FARALLON CAPITAL PARTNERS LP | 11,532,622 9.990% | 11,532,622 (New Position) | Filing History |
| 2023-02-03 5:15 pm Purchase | 2022-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | FARALLON CAPITAL PARTNERS LP | 1,417,917 9.990% | 1,417,917 (New Position) | Filing History |
| 2023-02-03 5:15 pm Sale | 2022-12-31 | 13G | ARAMARK ARMK | FARALLON CAPITAL PARTNERS LP | 14,998,004 4.200% | -7,593,263 (-33.61%) | Filing History |
| 2023-02-01 5:16 pm Sale | 2022-12-31 | 13G | IMAGO BIOSCIENCES INC IMGO | FARALLON CAPITAL PARTNERS LP | 0 0.000% | -2,671,313 (Position Closed) | Filing History |
| 2023-02-01 5:12 pm Purchase | 2022-12-31 | 13G | GENERATION BIO CO GBIO | FARALLON CAPITAL PARTNERS LP | 124,938 2.100% | 124,938 (New Position) | Filing History |
| 2023-02-01 5:09 pm Sale | 2022-12-31 | 13G | BIG SKY GROWTH PARTNERS INC BSKYW | FARALLON CAPITAL PARTNERS LP | 0 0.000% | -1,550,000 (Position Closed) | Filing History |
| 2023-01-31 5:18 pm Unchanged | 2022-12-31 | 13G | DISRUPTIVE ACQUISITION CORP I DISA | FARALLON CAPITAL PARTNERS LP | 1,400,000 5.100% | 0 (Unchanged) | Filing History |
| 2023-01-31 5:14 pm Purchase | 2022-12-31 | 13G | BERENSON ACQUISITION CORP I CL BACA | FARALLON CAPITAL PARTNERS LP | 2,662,500 9.600% | 187,500 (+7.58%) | Filing History |
| 2023-01-31 5:09 pm Unchanged | 2022-12-31 | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | FARALLON CAPITAL PARTNERS LP | 800,000 5.200% | 0 (Unchanged) | Filing History |
| 2022-10-07 3:12 pm Purchase | 2022-09-29 | 13D | CHANGE HEALTHCARE INC CHNG | FARALLON CAPITAL PARTNERS LP | 18,076,272 5.500% | 18,076,272 (New Position) | Filing History |
| 2022-09-06 5:41 pm Purchase | 2022-08-31 | 13G | CLARIVATE PLC CLVT | FARALLON CAPITAL PARTNERS LP | 35,325,900 5.200% | 35,325,900 (New Position) | Filing History |
| 2022-07-14 3:55 pm Purchase | 2022-07-05 | 13G | BEAM THERAPEUTICS INC BEAM | FARALLON CAPITAL PARTNERS LP | 3,551,771 5.100% | 3,551,771 (New Position) | Filing History |